Latest Articlesddd
BeiGene Ltd and EUSA Pharma Receive Approval from China NMPA for QARZIBA® BeiGene Ltd (BGNE) and EUSA …
Travere Therapeutics Sparsentan for IgAN Positive Results Phase 3 PROTECT Study of Travere Therapeutics (TVTX) product sparsentan …
Akero Therapeutics Inc Akero Therapeutics Inc (AKRO) is a clinical-stage cardio-metabolic company developing transformational treatments for …
Vir Biotechnology: What We've Learned from Dr. George Scangos George Scangos, PhD. is the chief executive …
Reata Pharmaceuticals Two Stories Omaveloxolone in Patients with Friedreich’s Ataxia Several communications between Reata Pharmaceuticals (RETA) …
Agenus Inc News and Q2 Results for 201 Agenus (AGEN) announced results with better than usual …
Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …
Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …
Novartis Partial Clinical Trial Hold for OAV-101 IT for SMA Lifted Novartis (NVS) announced that the …
Sanofi Will Acquire Translate Bio Sanofi (SNY) will acquire all the outstanding shares of Translate Bio (
Cassava Sciences There is no doubt in our minds that Cassava Sciences’ (SAVA) product simufilam will …
Cassava Sciences Inc Following Cassava Sciences Inc successful and promising presentations, all the titles of the …
Cassava Sciences Inc Press Release Related to Positive Biomarker Data Cassava Sciences Inc (SAVA) announced today, …
GlaxoSmithKline and Vir Biotechnology Signed a Joint Procurement Agreement with the EC GlaxoSmithKline (GSK) and Vir Biotechnology …
Cassava Sciences: Positive Clinical Data with SavaDX Cassava Sciences (SAVA) today announced positive clinical data with SavaDx, …
bluebird bio Receives EC Approval for bluebird bio (BLUE) announced that the European Commission (EC) has granted marketing authorization …
Cassava Sciences Soared Cassava Sciences (SAVA) stock soared today. The firm announced that it will present two …
Immunome Inc: Neutralizing SARS-C0V-2 Delta Variant Immunome Inc (IMNM) is a small biotech firm whose stock …
Cytokinetics Positive Topline Results of CK-274 Cytokinetics (CYTK) announced positive topline results of Phase 2 clinical …
Vir Biotechnology Vir Biotechnology (VIR) announced the dosing of the first patient in the Phase 2 …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
